Dynamic nuclear polarisation: The future of imaging in oncology?
- PMID: 32258590
- PMCID: PMC6806983
- DOI: 10.1016/j.pbj.2017.01.002
Dynamic nuclear polarisation: The future of imaging in oncology?
Abstract
As clinical oncology evolves with new treatment options becoming available, there is an increasing demand on anatomic imaging for the assessment of patients at different stages. Imaging with hyperpolarized 13C-labelled cell substrates has the potential to become a powerful tool in many steps of clinical evaluation, offering a new metabolic metric and therefore a more personalised approach to treatment response. This articles explores the metabolic basis and potential for translation of hyperpolarised pyruvate as a dynamic nuclear polarisation probe in clinical oncology.
Keywords: Cancer; Hyperpolarized; Imaging; Metabolism; Pyruvate.
Copyright 2017 PBJ-Associação Porto Biomedical/Porto Biomedical Society.
Conflict of interest statement
KB's lab has a research agreement with GE Healthcare (GEH) and holds patents on DNP technology with GEH.
Figures
References
-
- Warburg O. On respiratory impairment in cancer cells. Science. 1956;124:269-270. - PubMed
-
- Warburg O. On the origin of cancer cells. Science. 1956;123:309-314. - PubMed
-
- Semenza GL, Artemov D, Bedi A, Bhujwalla Z, Chiles K, Feldser D, et al. 'The metabolism of tumours': 70 years later. Novartis Found Symp. 2001;240:251-260. discussion 60-4. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials